Mitra Biotech Garners $27,400,000 Series B Financing Round

  • Feed Type
  • Date
    8/31/2016
  • Company Name
    Mitra Biotech
  • Mailing Address
    12 Gill St. Woburn, MA 01801 USA
  • Company Description
    Mitra Biotech is the global leader in therapy selection in oncology. Mitra is led by an accomplished team of diagnostic and drug development professionals and is backed by world leading venture groups with long term commitment to Mitra’s vision in personalized cancer care.
  • Website
    http://www.mitrabiotech.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,400,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Mitra will use the funds to expand the availability of its CANScript service, which predicts personalised responses to cancer treatments.
  • M&A Terms
  • Venture Investor
    Sequoia India
  • Venture Investor
    Sands Capital Management
  • Venture Investor
    RA Capital
  • Venture Investor
    Accel Partners
  • Venture Investor
    Tata Industries

Trending on Xconomy